The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.94BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
87.02x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Revenue (TTM)
2.16BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
2.15%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Beta
0.7600x
vs all stocks
Updated Jul 19, 2026
52-Week Change
29.47%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
3.94BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
4.99BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
87.02x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Forward P/E
16.87x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
PEG Ratio
-0.2963x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Price to Sales (TTM)
1.83x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Price to Book (MRQ)
1.86x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Enterprise to Revenue
2.31x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Enterprise to EBITDA
16.01x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 15.55×.Updated Jul 19, 2026
Gross Margin
38.89%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Profit Margin
2.15%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Operating Margin
5.73%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Return on Assets (TTM)
1.68%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Return on Equity (TTM)
2.26%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Revenue (TTM)
2.16BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
87.33USDUpdated Jul 19, 2026
Quarterly Revenue Growth
-12.30%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Gross Profit (TTM)
818.16MUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
320.66MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
46.34MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
-12.32%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Operating Cash Flow (TTM)
167.43MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
387.08MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Revenue
2.23BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.41BUSDFY2025 · Dec 31, 2025
Gross Profit
822.04MUSDFY2025 · Dec 31, 2025
Operating Income
109.33MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
4.36MUSDFY2025 · Dec 31, 2025
Income Tax Expense
2.44MUSDFY2025 · Dec 31, 2025
Net Income
732.00KUSDFY2025 · Dec 31, 2025
EBIT
97.70MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
320.73MUSDFY2025 · Dec 31, 2025
Research & Development
87.50MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
625.21MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
10.31MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
93.34MUSDFY2025 · Dec 31, 2025
EPS (Basic)
0.0300USDFY2025 · Dec 31, 2025
EPS (Diluted)
0.0300USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
24.64MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
24.64MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
732.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
263.01MUSDFY2025 · Dec 31, 2025
Free Cash Flow
174.97MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
307.96MUSDFY2025 · Dec 31, 2025
Interest Paid
83.74MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
732.00KUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
200.74MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
55.76MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
47.90MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
8.88MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
7.00MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-57.99MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-88.04MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-8.97MUSDFY2025 · Dec 31, 2025
Net Acquisitions
211.19MUSDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Other Investing Activity
8.06MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
131.20MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
313.00KUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-304.80MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-13.15MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-317.63MUSDFY2025 · Dec 31, 2025
Shares Outstanding
24.99MSharesUpdated Jul 19, 2026
Float Shares
24.51MSharesUpdated Jul 19, 2026
Shares Short
1.69MSharesUpdated Jul 19, 2026
Short Ratio
5.36days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
8.08%
vs all stocks
Updated Jul 19, 2026
% Held by Insiders
1.92%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
114.93%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
292.68MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
11.71USDUpdated Jul 19, 2026
Total Debt (MRQ)
1.34BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
0.6362x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Current Ratio (MRQ)
2.34x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Book Value per Share (MRQ)
84.50USDUpdated Jul 19, 2026
Total Assets
4.05BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.19BUSDFY2025 · Dec 31, 2025
Total Liabilities
1.93BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
2.86BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.43BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
498.86MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
307.96MUSDFY2025 · Dec 31, 2025
Accounts Receivable
180.51MUSDFY2025 · Dec 31, 2025
Inventory
615.86MUSDFY2025 · Dec 31, 2025
Accounts Payable
154.37MUSDFY2025 · Dec 31, 2025
Short-term Debt
18.75MUSDFY2025 · Dec 31, 2025
Deferred Revenue
33.84MUSDFY2025 · Dec 31, 2025
Long-term Debt
1.31BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
41.86MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
2.47MUSDFY2025 · Dec 31, 2025
Retained Earnings
690.89MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.12BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
22.00KUSDFY2025 · Dec 31, 2025
52-Week Low
107.00USDUpdated Jul 19, 2026
52-Week High
162.85USDUpdated Jul 19, 2026
52-Week Change
29.47%
vs all stocks
Updated Jul 19, 2026
Beta
0.7600x
vs all stocks
Updated Jul 19, 2026
50-Day MA
139.56USDUpdated Jul 19, 2026
200-Day MA
137.07USDUpdated Jul 19, 2026
Avg 10-Day Volume
260.41KSharesUpdated Jul 19, 2026
Avg 30-Day Volume
301.50KSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
1.81USDUpdated Jul 19, 2026
Other Income / Expense
-21.95MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.3: grey zoneSignificant
Altman Z-Score: 2.30
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $3.94B, above the global median of $1.15BNotable
Market cap (USD): 3,936,739,323Global Median: 1,146,734,693.424
Revenue is $2.16B, above the global median of $520.53MNotable